WallStreetZenWallStreetZen

NASDAQ: PAHC
Phibro Animal Health Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for PAHC

Based on 2 analysts offering 12 month price targets for Phibro Animal Health Corp.
Min Forecast
$16.00+44.4%
Avg Forecast
$18.50+66.97%
Max Forecast
$21.00+89.53%

Should I buy or sell PAHC stock?

Based on 2 analysts offering ratings for Phibro Animal Health Corp.
Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PAHC stock forecasts and price targets.

PAHC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-09
lockedlocked$00.00+00.00%2023-09-01

1 of 1

Forecast return on equity

Is PAHC forecast to generate an efficient return?
Company
N/A
Industry
0.06%
Market
30.34%

Forecast return on assets

Is PAHC forecast to generate an efficient return on assets?
Company
N/A
Industry
0.04%

PAHC revenue forecast

What is PAHC's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$982.5M+0.59%
Avg 2 year Forecast
$1.0B+6.36%
Avg 3 year Forecast
$1.1B+10.33%
PAHC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PAHC earnings growth forecast

How is PAHC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
48.71%
Industry
14.18%
Market
17.9%
PAHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PAHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PAHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PAHC revenue growth forecast

How is PAHC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
3.46%
Industry
6.44%
Market
7.68%
PAHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PAHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PAHC vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
PAHC$11.08$18.50+66.97%Buy
SIGA$6.25N/AN/A
ORGO$3.33$3.75+12.61%Buy
PETQ$17.73$29.33+65.44%Strong Buy
HROW$9.79$45.00+359.65%Strong Buy
View Top Pharmaceutical Stocks

Phibro Animal Health Stock Forecast FAQ

Is Phibro Animal Health Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: PAHC) stock is to Buy PAHC stock.

Out of 2 analysts, 1 (50%) are recommending PAHC as a Strong Buy, 0 (0%) are recommending PAHC as a Buy, 1 (50%) are recommending PAHC as a Hold, 0 (0%) are recommending PAHC as a Sell, and 0 (0%) are recommending PAHC as a Strong Sell.

If you're new to stock investing, here's how to buy Phibro Animal Health stock.

What is PAHC's revenue growth forecast for 2024-2026?

(NASDAQ: PAHC) Phibro Animal Health's forecast annual revenue growth rate of 3.46% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.68%.

Phibro Animal Health's revenue in 2023 is $976,717,000.On average, 3 Wall Street analysts forecast PAHC's revenue for 2024 to be $39,793,336,730, with the lowest PAHC revenue forecast at $39,125,675,256, and the highest PAHC revenue forecast at $40,526,046,999. On average, 3 Wall Street analysts forecast PAHC's revenue for 2025 to be $42,075,917,559, with the lowest PAHC revenue forecast at $42,000,540,344, and the highest PAHC revenue forecast at $42,156,965,279.

In 2026, PAHC is forecast to generate $43,647,012,010 in revenue, with the lowest revenue forecast at $43,567,543,931 and the highest revenue forecast at $43,726,480,089.

What is PAHC's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: PAHC) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.04%.

What is PAHC's Price Target?

According to 2 Wall Street analysts that have issued a 1 year PAHC price target, the average PAHC price target is $18.50, with the highest PAHC stock price forecast at $21.00 and the lowest PAHC stock price forecast at $16.00.

On average, Wall Street analysts predict that Phibro Animal Health's share price could reach $18.50 by Nov 9, 2024. The average Phibro Animal Health stock price prediction forecasts a potential upside of 66.97% from the current PAHC share price of $11.08.

What is PAHC's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: PAHC) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.